<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32397312</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>9</Issue><PubDate><Year>2020</Year><Month>May</Month><Day>08</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Burden of Rare Variants in ALS and Axonal Hereditary Neuropathy Genes Influence Survival in ALS: Insights from a Next Generation Sequencing Study of an Italian ALS Cohort.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3346</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21093346</ELocationID><Abstract><AbstractText>Although the genetic architecture of amyotrophic lateral sclerosis (ALS) is incompletely understood, recent findings suggest a complex model of inheritance in ALS, which is consistent with a multistep pathogenetic process. Therefore, the aim of our work is to further explore the architecture of ALS using targeted next generation sequencing (NGS) analysis, enriched in motor neuron diseases (MND)-associated genes which are also implicated in axonal hereditary motor neuropathy (HMN), in order to investigate if disease expression, including the progression rate, could be influenced by the combination of multiple rare gene variants. We analyzed 29 genes in an Italian cohort of 83 patients with both familial and sporadic ALS. Overall, we detected 43 rare variants in 17 different genes and found that 43.4% of the ALS patients harbored a variant in at least one of the investigated genes. Of note, 27.9% of the variants were identified in other MND- and HMN-associated genes. Moreover, multiple gene variants were identified in 17% of the patients. The burden of rare variants is associated with reduced survival and with the time to reach King stage 4, i.e., the time to reach the need for percutaneous endoscopic gastrostomy (PEG) positioning or non-invasive mechanical ventilation (NIMV) initiation, independently of known negative prognostic factors. Our data contribute to a better understanding of the molecular basis of ALS supporting the hypothesis that rare variant burden could play a role in the multistep model of disease and could exert a negative prognostic effect. Moreover, we further extend the genetic landscape of ALS to other MND-associated genes traditionally implicated in degenerative diseases of peripheral axons, such as HMN and CMT2.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scarlino</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Domi</LastName><ForeName>Teuta</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pozzi</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romano</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pipitone</LastName><ForeName>Giovanni Battista</ForeName><Initials>GB</Initials><Identifier Source="ORCID">0000-0003-2265-3646</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Molecular Biology, Unit of Genomics for human disease diagnosis, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falzone</LastName><ForeName>Yuri Matteo</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosca</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical Genetic Unit, Department of Laboratory Medicine, Niguarda Hospital, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penco</LastName><ForeName>Silvana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Genetic Unit, Department of Laboratory Medicine, Niguarda Hospital, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lunetta</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan 20132, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sansone</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>NEuroMuscular Omnicentre (NEMO), Fondazione Serena Onlus, Milan 20132, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Biomedical Sciences of Health, University of Milan, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tremolizzo</LastName><ForeName>Lucio</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neurology Unit, "San Gerardo" Hospital and University of Milano-Bicocca, 20900 Monza, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fazio</LastName><ForeName>Raffaella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Neurology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agosta</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuroimaging Research Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filippi</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neurology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroimaging Research Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurophysiology Unit, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Vita-Salute San Raffaele University,20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carrera</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Molecular Biology, Unit of Genomics for human disease diagnosis, Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riva</LastName><ForeName>Nilo</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neurology Unit, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quattrini</LastName><ForeName>Angelo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Experimental Neuropathology Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>#RF-2011-02351193</GrantID><Agency>Italian Ministry of Health</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>05</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053208" MajorTopicYN="N">Kaplan-Meier Estimate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="N">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="N">Muscular Atrophy, Spinal</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CMT</Keyword><Keyword MajorTopicYN="N">distal SMA</Keyword><Keyword MajorTopicYN="N">genetics</Keyword><Keyword MajorTopicYN="N">hereditary neuropathy</Keyword><Keyword MajorTopicYN="N">lower motor neuron syndrome</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">nerve</Keyword><Keyword MajorTopicYN="N">neuropathy</Keyword><Keyword MajorTopicYN="N">next generation sequencing</Keyword><Keyword MajorTopicYN="N">survival</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32397312</ArticleId><ArticleId IdType="pmc">PMC7246633</ArticleId><ArticleId IdType="doi">10.3390/ijms21093346</ArticleId><ArticleId IdType="pii">ijms21093346</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Riva N., Agosta F., Lunetta C., Filippi M., Quattrini A. Recent advances in amyotrophic lateral sclerosis. J. Neurol. 2016;263:1241&#x2013;1254. doi: 10.1007/s00415-016-8091-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8091-6</ArticleId><ArticleId IdType="pmc">PMC4893385</ArticleId><ArticleId IdType="pubmed">27025851</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Es M.A., Hardiman O., Chio A., Al-Chalabi A., Pasterkamp R.J., Veldink J.H., van den Berg L.H. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Traynor B.J., Hardiman O., Chio A., Mitchell D., Swingler R.J., Millul A., Benn E., Beghi E. Incidence of amyotrophic lateral sclerosis in europe. J. Neurol. Neurosurg. Psychiatry. 2010;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Chio A., Traynor B.J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 2014;17:17&#x2013;23. doi: 10.1038/nn.3584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Fang F., Hanby M.F., Leigh P.N., Shaw C.E., Ye W., Rijsdijk F. An estimate of amyotrophic lateral sclerosis heritability using twin data. J. Neurol. Neurosurg. Psychiatry. 2010;81:1324&#x2013;1326. doi: 10.1136/jnnp.2010.207464.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.207464</ArticleId><ArticleId IdType="pmc">PMC2988617</ArticleId><ArticleId IdType="pubmed">20861059</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Calvo A., Chio A., Colville S., Ellis C.M., Hardiman O., Heverin M., Howard R.S., Huisman M.H.B., Keren N., et al. Analysis of amyotrophic lateral sclerosis as a multistep process: A population-based modelling study. Lancet Neurol. 2014;13:1108&#x2013;1113. doi: 10.1016/S1474-4422(14)70219-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId><ArticleId IdType="pmc">PMC4197338</ArticleId><ArticleId IdType="pubmed">25300936</ArticleId></ArticleIdList></Reference><Reference><Citation>The scottish motor neuron disease register: A prospective study of adult onset motor neuron disease in scotland. Methodology, demography and clinical features of incident cases in 1989. J. Neurol. Neurosurg. Psychiatry. 1992;55:536&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC489161</ArticleId><ArticleId IdType="pubmed">1640227</ArticleId></ArticleIdList></Reference><Reference><Citation>Cady J., Allred P., Bali T., Pestronk A., Goate A., Miller T.M., Mitra R.D., Ravits J., Harms M.B., Baloh R.H. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann. Neurol. 2015;77:100&#x2013;113. doi: 10.1002/ana.24306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24306</ArticleId><ArticleId IdType="pmc">PMC4293318</ArticleId><ArticleId IdType="pubmed">25382069</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile F., Scarlino S., Falzone Y.M., Lunetta C., Tremolizzo L., Quattrini A., Riva N. The peripheral nervous system in amyotrophic lateral sclerosis: Opportunities for translational research. Front. Neurosci. 2019;13:601. doi: 10.3389/fnins.2019.00601.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00601</ArticleId><ArticleId IdType="pmc">PMC6603245</ArticleId><ArticleId IdType="pubmed">31293369</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N., Iannaccone S., Corbo M., Casellato C., Sferrazza B., Lazzerini A., Scarlato M., Cerri F., Previtali S.C., Nobile-Orazio E., et al. Motor nerve biopsy: Clinical usefulness and histopathological criteria. Ann. Neurol. 2011;69:197&#x2013;201. doi: 10.1002/ana.22110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22110</ArticleId><ArticleId IdType="pubmed">21280090</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Galantucci S., Magnani G., Marcone A., Martinelli D., Antonietta Volonte M., Riva N., Iannaccone S., Ferraro P.M., Caso F., et al. Mri signatures of the frontotemporal lobar degeneration continuum. Hum. Brain Mapp. 2015;36:2602&#x2013;2614. doi: 10.1002/hbm.22794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.22794</ArticleId><ArticleId IdType="pmc">PMC6869605</ArticleId><ArticleId IdType="pubmed">25821176</ArticleId></ArticleIdList></Reference><Reference><Citation>Orrell R.W., Marklund S.L., deBelleroche J.S. Familial als is associated with mutations in all exons of sod1: A novel mutation in exon 3 (gly72ser) J. Neurol. Sci. 1997;153:46&#x2013;49. doi: 10.1016/S0022-510X(97)00181-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(97)00181-0</ArticleId><ArticleId IdType="pubmed">9455977</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi Z., Tsuchiya K., Kubodera T., Shibata N., Arai T., Miura H., Ishikawa C., Kondo H., Ishizu H., Akiyama H., et al. Fals with gly72ser mutation in sod1 gene: Report of a family including the first autopsy case. J. Neurol. Sci. 2011;300:9&#x2013;13. doi: 10.1016/j.jns.2010.10.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.10.030</ArticleId><ArticleId IdType="pubmed">21084099</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Grande A., Luigetti M., Conte A., Mancuso I., Lattante S., Marangi G., Stipa G., Zollino M., Sabatelli M. A novel l67p sod1 mutation in an italian als patient. Amyotroph. Lateral Scler. 2011;12:150&#x2013;152. doi: 10.3109/17482968.2011.551939.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.551939</ArticleId><ArticleId IdType="pubmed">21247266</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna K.P., McLaughlin R.L., Byrne S., Elamin M., Heverin M., Kenny E.M., Cormican P., Morris D.W., Donaghy C.G., Bradley D.G., et al. Delineating the genetic heterogeneity of als using targeted high-throughput sequencing. J. Med. Genet. 2013;50:776&#x2013;783. doi: 10.1136/jmedgenet-2013-101795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2013-101795</ArticleId><ArticleId IdType="pmc">PMC3812897</ArticleId><ArticleId IdType="pubmed">23881933</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozzi L., Valenza F., Mosca L., Dal Mas A., Domi T., Romano A., Tarlarini C., Falzone Y.M., Tremolizzo L., Soraru G., et al. Tbk1 mutations in italian patients with amyotrophic lateral sclerosis: Genetic and functional characterisation. J. Neurol. Neurosurg. Psychiatry. 2017;88:869&#x2013;875. doi: 10.1136/jnnp-2017-316174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316174</ArticleId><ArticleId IdType="pmc">PMC5629935</ArticleId><ArticleId IdType="pubmed">28822984</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger S., Battke F., Sprecher A., Munz M., Synofzik M., Schols L., Gasser T., Grehl T., Prudlo J., Biskup S. Rare variants in neurodegeneration associated genes revealed by targeted panel sequencing in a german als cohort. Front. Mol. Neurosci. 2016;9:92. doi: 10.3389/fnmol.2016.00092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2016.00092</ArticleId><ArticleId IdType="pmc">PMC5061735</ArticleId><ArticleId IdType="pubmed">27790088</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S., Shoai M., Fratta P., Sidle K., Orrell R., Sweeney M.G., Shatunov A., Sproviero W., Jones A., Al-Chalabi A., et al. Investigation of next-generation sequencing technologies as a diagnostic tool for amyotrophic lateral sclerosis. Neurobiol. Aging. 2015;36:1600.e5&#x2013;1600.e8. doi: 10.1016/j.neurobiolaging.2014.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.12.017</ArticleId><ArticleId IdType="pubmed">25588603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernard V., Stricker S., Kreuz F., Minnerop M., Gillessen-Kaesbach G., Zuhlke C. Ataxia with oculomotor apraxia type 2: Novel mutations in six patients with juvenile age of onset and elevated serum alpha-fetoprotein. Neuropediatrics. 2008;39:347&#x2013;350. doi: 10.1055/s-0029-1214424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0029-1214424</ArticleId><ArticleId IdType="pubmed">19569000</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoyer H., Braathen G.J., Busk O.L., Holla O.L., Svendsen M., Hilmarsen H.T., Strand L., Skjelbred C.F., Russell M.B. Genetic diagnosis of charcot-marie-tooth disease in a population by next-generation sequencing. Biomed. Res. Int. 2014;2014:210401. doi: 10.1155/2014/210401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/210401</ArticleId><ArticleId IdType="pmc">PMC4082881</ArticleId><ArticleId IdType="pubmed">25025039</ArticleId></ArticleIdList></Reference><Reference><Citation>Arning L., Epplen J.T., Rahikkala E., Hendrich C., Ludolph A.C., Sperfeld A.D. The setx missense variation spectrum as evaluated in patients with als4-like motor neuron diseases. Neurogenetics. 2013;14:53&#x2013;61. doi: 10.1007/s10048-012-0347-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10048-012-0347-4</ArticleId><ArticleId IdType="pubmed">23129421</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensato V., Castellotti B., Gellera C., Pareyson D., Ciano C., Nanetti L., Salsano E., Piscosquito G., Sarto E., Eoli M., et al. Overlapping phenotypes in complex spastic paraplegias spg11, spg15, spg35 and spg48. Brain. 2014;137:1907&#x2013;1920. doi: 10.1093/brain/awu121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu121</ArticleId><ArticleId IdType="pubmed">24833714</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow C.Y., Zhang Y., Dowling J.J., Jin N., Adamska M., Shiga K., Szigeti K., Shy M.E., Li J., Zhang X., et al. Mutation of fig4 causes neurodegeneration in the pale tremor mouse and patients with cmt4j. Nature. 2007;448:68&#x2013;72. doi: 10.1038/nature05876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05876</ArticleId><ArticleId IdType="pmc">PMC2271033</ArticleId><ArticleId IdType="pubmed">17572665</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson G., Lenk G.M., Reddel S.W., Grant A.E., Towne C.F., Ferguson C.J., Simpson E., Scheuerle A., Yasick M., Hoffman S., et al. Distinctive genetic and clinical features of cmt4j: A severe neuropathy caused by mutations in the pi(3,5)p(2) phosphatase fig4. Brain. 2011;134:1959&#x2013;1971. doi: 10.1093/brain/awr148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr148</ArticleId><ArticleId IdType="pmc">PMC3122378</ArticleId><ArticleId IdType="pubmed">21705420</ArticleId></ArticleIdList></Reference><Reference><Citation>Menezes M.P., Waddell L., Lenk G.M., Kaur S., MacArthur D.G., Meisler M.H., Clarke N.F. Whole exome sequencing identifies three recessive fig4 mutations in an apparently dominant pedigree with charcot-marie-tooth disease. Neuromuscul. Disord. 2014;24:666&#x2013;670. doi: 10.1016/j.nmd.2014.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2014.04.010</ArticleId><ArticleId IdType="pmc">PMC4096049</ArticleId><ArticleId IdType="pubmed">24878229</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenk G.M., Ferguson C.J., Chow C.Y., Jin N., Jones J.M., Grant A.E., Zolov S.N., Winters J.J., Giger R.J., Dowling J.J., et al. Pathogenic mechanism of the fig4 mutation responsible for charcot-marie-tooth disease cmt4j. PLoS Genet. 2011;7:e1002104. doi: 10.1371/journal.pgen.1002104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1002104</ArticleId><ArticleId IdType="pmc">PMC3107197</ArticleId><ArticleId IdType="pubmed">21655088</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow C.Y., Landers J.E., Bergren S.K., Sapp P.C., Grant A.E., Jones J.M., Everett L., Lenk G.M., McKenna-Yasek D.M., Weisman L.S., et al. Deleterious variants of fig4, a phosphoinositide phosphatase, in patients with als. Am. J. Hum. Genet. 2009;84:85&#x2013;88. doi: 10.1016/j.ajhg.2008.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2008.12.010</ArticleId><ArticleId IdType="pmc">PMC2668033</ArticleId><ArticleId IdType="pubmed">19118816</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanovic A., Rangnau I., Kosfeld A., Abdulla S., Janssen C., Auber B., Raab P., Preller M., Petri S., Weber R.G. Fig4 variants in central european patients with amyotrophic lateral sclerosis: A whole-exome and targeted sequencing study. Eur. J. Hum. Genet. 2017;25:324&#x2013;331. doi: 10.1038/ejhg.2016.186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2016.186</ArticleId><ArticleId IdType="pmc">PMC5315518</ArticleId><ArticleId IdType="pubmed">28051077</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi Y., Fukuda Y., Yoshimura J., Toyoda A., Kurppa K., Moritoyo H., Belzil V.V., Dion P.A., Higasa K., Doi K., et al. Erbb4 mutations that disrupt the neuregulin-erbb4 pathway cause amyotrophic lateral sclerosis type 19. Am. J. Hum. Genet. 2013;93:900&#x2013;905. doi: 10.1016/j.ajhg.2013.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2013.09.008</ArticleId><ArticleId IdType="pmc">PMC3824132</ArticleId><ArticleId IdType="pubmed">24119685</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudloff U., Samuels Y. A growing family: Adding mutated erbb4 as a novel cancer target. Cell Cycle. 2010;9:1487&#x2013;1503. doi: 10.4161/cc.9.8.11239.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.9.8.11239</ArticleId><ArticleId IdType="pmc">PMC3384517</ArticleId><ArticleId IdType="pubmed">20404484</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevanin G., Azzedine H., Denora P., Boukhris A., Tazir M., Lossos A., Rosa A.L., Lerer I., Hamri A., Alegria P., et al. Mutations in spg11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain. 2008;131:772&#x2013;784. doi: 10.1093/brain/awm293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm293</ArticleId><ArticleId IdType="pubmed">18079167</ArticleId></ArticleIdList></Reference><Reference><Citation>Denora P.S., Schlesinger D., Casali C., Kok F., Tessa A., Boukhris A., Azzedine H., Dotti M.T., Bruno C., Truchetto J., et al. Screening of arhsp-tcc patients expands the spectrum of spg11 mutations and includes a large scale gene deletion. Hum. Mutat. 2009;30:E500&#x2013;E519. doi: 10.1002/humu.20945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20945</ArticleId><ArticleId IdType="pubmed">19105190</ArticleId></ArticleIdList></Reference><Reference><Citation>DiVincenzo C., Elzinga C.D., Medeiros A.C., Karbassi I., Jones J.R., Evans M.C., Braastad C.D., Bishop C.M., Jaremko M., Wang Z., et al. The allelic spectrum of charcot-marie-tooth disease in over 17,000 individuals with neuropathy. Mol. Genet. Genom. Med. 2014;2:522&#x2013;529. doi: 10.1002/mgg3.106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mgg3.106</ArticleId><ArticleId IdType="pmc">PMC4303222</ArticleId><ArticleId IdType="pubmed">25614874</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuyvers E., van der Zee J., Bettens K., Engelborghs S., Vandenbulcke M., Robberecht C., Dillen L., Merlin C., Geerts N., Graff C., et al. Genetic variability in sqstm1 and risk of early-onset alzheimer dementia: A european early-onset dementia consortium study. Neurobiol. Aging. 2015;36:2005.e15&#x2013;2005.e22. doi: 10.1016/j.neurobiolaging.2015.02.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.02.014</ArticleId><ArticleId IdType="pubmed">25796131</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Zee J., Van Langenhove T., Kovacs G.G., Dillen L., Deschamps W., Engelborghs S., Matej R., Vandenbulcke M., Sieben A., Dermaut B., et al. Rare mutations in sqstm1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol. 2014;128:397&#x2013;410. doi: 10.1007/s00401-014-1298-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1298-7</ArticleId><ArticleId IdType="pmc">PMC4131163</ArticleId><ArticleId IdType="pubmed">24899140</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Grubor V., Love C.L., Banerjee A., Richards K.L., Mieczkowski P.A., Dunphy C., Choi W., Au W.Y., Srivastava G., et al. Genetic heterogeneity of diffuse large b-cell lymphoma. Proc. Natl. Acad. Sci. USA. 2013;110:1398&#x2013;1403. doi: 10.1073/pnas.1205299110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1205299110</ArticleId><ArticleId IdType="pmc">PMC3557051</ArticleId><ArticleId IdType="pubmed">23292937</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannakis M., Hodis E., Jasmine Mu X., Yamauchi M., Rosenbluh J., Cibulskis K., Saksena G., Lawrence M.S., Qian Z.R., Nishihara R., et al. Rnf43 is frequently mutated in colorectal and endometrial cancers. Nat. Genet. 2014;46:1264&#x2013;1266. doi: 10.1038/ng.3127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3127</ArticleId><ArticleId IdType="pmc">PMC4283570</ArticleId><ArticleId IdType="pubmed">25344691</ArticleId></ArticleIdList></Reference><Reference><Citation>Morelli F.F., Verbeek D.S., Bertacchini J., Vinet J., Mediani L., Marmiroli S., Cenacchi G., Nasi M., De Biasi S., Brunsting J.F., et al. Aberrant compartment formation by hspb2 mislocalizes lamin a and compromises nuclear integrity and function. Cell Rep. 2017;20:2100&#x2013;2115. doi: 10.1016/j.celrep.2017.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.08.018</ArticleId><ArticleId IdType="pmc">PMC5583511</ArticleId><ArticleId IdType="pubmed">28854361</ArticleId></ArticleIdList></Reference><Reference><Citation>Morais S., Raymond L., Mairey M., Coutinho P., Brandao E., Ribeiro P., Loureiro J.L., Sequeiros J., Brice A., Alonso I., et al. Massive sequencing of 70 genes reveals a myriad of missing genes or mechanisms to be uncovered in hereditary spastic paraplegias. Eur. J. Hum. Genet. 2017;25:1217&#x2013;1228. doi: 10.1038/ejhg.2017.124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ejhg.2017.124</ArticleId><ArticleId IdType="pmc">PMC5643959</ArticleId><ArticleId IdType="pubmed">28832565</ArticleId></ArticleIdList></Reference><Reference><Citation>Casasnovas C., Banchs I., Cassereau J., Gueguen N., Chevrollier A., Martinez-Matos J.A., Bonneau D., Volpini V. Phenotypic spectrum of mfn2 mutations in the spanish population. J. Med. Genet. 2010;47:249&#x2013;256. doi: 10.1136/jmg.2009.072488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2009.072488</ArticleId><ArticleId IdType="pubmed">19889647</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelfried K., Vorgerd M., Hagedorn M., Haas G., Gilles J., Epplen J.T., Meins M. Charcot-marie-tooth neuropathy type 2a: Novel mutations in the mitofusin 2 gene (mfn2) BMC Med. Genet. 2006;7:53. doi: 10.1186/1471-2350-7-53.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2350-7-53</ArticleId><ArticleId IdType="pmc">PMC1524942</ArticleId><ArticleId IdType="pubmed">16762064</ArticleId></ArticleIdList></Reference><Reference><Citation>McCorquodale D.S., 3rd, Montenegro G., Peguero A., Carlson N., Speziani F., Price J., Taylor S.W., Melanson M., Vance J.M., Zuchner S. Mutation screening of mitofusin 2 in charcot-marie-tooth disease type 2. J. Neurol. 2011;258:1234&#x2013;1239. doi: 10.1007/s00415-011-5910-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-011-5910-7</ArticleId><ArticleId IdType="pmc">PMC3125445</ArticleId><ArticleId IdType="pubmed">21258814</ArticleId></ArticleIdList></Reference><Reference><Citation>Cassereau J., Casasnovas C., Gueguen N., Malinge M.C., Guillet V., Reynier P., Bonneau D., Amati-Bonneau P., Banchs I., Volpini V., et al. Simultaneous mfn2 and gdap1 mutations cause major mitochondrial defects in a patient with cmt. Neurology. 2011;76:1524&#x2013;1526. doi: 10.1212/WNL.0b013e318217e77d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318217e77d</ArticleId><ArticleId IdType="pubmed">21519004</ArticleId></ArticleIdList></Reference><Reference><Citation>Braathen G.J., Sand J.C., Lobato A., Hoyer H., Russell M.B. Mfn2 point mutations occur in 3.4% of charcot-marie-tooth families. An investigation of 232 norwegian cmt families. BMC Med. Genet. 2010;11:48. doi: 10.1186/1471-2350-11-48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2350-11-48</ArticleId><ArticleId IdType="pmc">PMC2859816</ArticleId><ArticleId IdType="pubmed">20350294</ArticleId></ArticleIdList></Reference><Reference><Citation>Antoniadi T., Buxton C., Dennis G., Forrester N., Smith D., Lunt P., Burton-Jones S. Application of targeted multi-gene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variability. BMC Med. Genet. 2015;16:84. doi: 10.1186/s12881-015-0224-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12881-015-0224-8</ArticleId><ArticleId IdType="pmc">PMC4578331</ArticleId><ArticleId IdType="pubmed">26392352</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez-Ferrero E., Coto E., Beetz C., Gamez J., Corao A.I., Diaz M., Esteban J., del Castillo E., Moris G., Infante J., et al. Spg7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510v. Clin. Genet. 2013;83:257&#x2013;262. doi: 10.1111/j.1399-0004.2012.01896.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2012.01896.x</ArticleId><ArticleId IdType="pubmed">22571692</ArticleId></ArticleIdList></Reference><Reference><Citation>Roxburgh R.H., Marquis-Nicholson R., Ashton F., George A.M., Lea R.A., Eccles D., Mossman S., Bird T., van Gassen K.L., Kamsteeg E.J., et al. The p.Ala510val mutation in the spg7 (paraplegin) gene is the most common mutation causing adult onset neurogenetic disease in patients of british ancestry. J. Neurol. 2013;260:1286&#x2013;1294. doi: 10.1007/s00415-012-6792-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6792-z</ArticleId><ArticleId IdType="pubmed">23269439</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermott C.J., Dayaratne R.K., Tomkins J., Lusher M.E., Lindsey J.C., Johnson M.A., Casari G., Turnbull D.M., Bushby K., Shaw P.J. Paraplegin gene analysis in hereditary spastic paraparesis (hsp) pedigrees in northeast england. Neurology. 2001;56:467&#x2013;471. doi: 10.1212/WNL.56.4.467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.56.4.467</ArticleId><ArticleId IdType="pubmed">11222789</ArticleId></ArticleIdList></Reference><Reference><Citation>Klebe S., Depienne C., Gerber S., Challe G., Anheim M., Charles P., Fedirko E., Lejeune E., Cottineau J., Brusco A., et al. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. Brain. 2012;135:2980&#x2013;2993. doi: 10.1093/brain/aws240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws240</ArticleId><ArticleId IdType="pmc">PMC3470714</ArticleId><ArticleId IdType="pubmed">23065789</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeffer G., Gorman G.S., Griffin H., Kurzawa-Akanbi M., Blakely E.L., Wilson I., Sitarz K., Moore D., Murphy J.L., Alston C.L., et al. Mutations in the spg7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance. Brain. 2014;137:1323&#x2013;1336. doi: 10.1093/brain/awu060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu060</ArticleId><ArticleId IdType="pmc">PMC3999722</ArticleId><ArticleId IdType="pubmed">24727571</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonn F., Pantakani K., Shoukier M., Langer T., Mannan A.U. Functional evaluation of paraplegin mutations by a yeast complementation assay. Hum. Mutat. 2010;31:617&#x2013;621. doi: 10.1002/humu.21226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.21226</ArticleId><ArticleId IdType="pubmed">20186691</ArticleId></ArticleIdList></Reference><Reference><Citation>Munch C., Sedlmeier R., Meyer T., Homberg V., Sperfeld A.D., Kurt A., Prudlo J., Peraus G., Hanemann C.O., Stumm G., et al. Point mutations of the p150 subunit of dynactin (dctn1) gene in als. Neurology. 2004;63:724&#x2013;726. doi: 10.1212/01.WNL.0000134608.83927.B1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000134608.83927.B1</ArticleId><ArticleId IdType="pubmed">15326253</ArticleId></ArticleIdList></Reference><Reference><Citation>Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., et al. Mutant dynactin in motor neuron disease. Nat. Genet. 2003;33:455&#x2013;456. doi: 10.1038/ng1123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1123</ArticleId><ArticleId IdType="pubmed">12627231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupo V., Aguado C., Knecht E., Espinos C. Chaperonopathies: Spotlight on hereditary motor neuropathies. Front. Mol. Biosci. 2016;3:81. doi: 10.3389/fmolb.2016.00081.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2016.00081</ArticleId><ArticleId IdType="pmc">PMC5155517</ArticleId><ArticleId IdType="pubmed">28018906</ArticleId></ArticleIdList></Reference><Reference><Citation>Evgrafov O.V., Mersiyanova I., Irobi J., Van Den Bosch L., Dierick I., Leung C.L., Schagina O., Verpoorten N., Van Impe K., Fedotov V., et al. Mutant small heat-shock protein 27 causes axonal charcot-marie-tooth disease and distal hereditary motor neuropathy. Nat. Genet. 2004;36:602&#x2013;606. doi: 10.1038/ng1354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1354</ArticleId><ArticleId IdType="pubmed">15122254</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiorillo C., Moro F., Yi J., Weil S., Brisca G., Astrea G., Severino M., Romano A., Battini R., Rossi A., et al. Novel dynein dync1h1 neck and motor domain mutations link distal spinal muscular atrophy and abnormal cortical development. Hum. Mutat. 2014;35:298&#x2013;302. doi: 10.1002/humu.22491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22491</ArticleId><ArticleId IdType="pmc">PMC4109683</ArticleId><ArticleId IdType="pubmed">24307404</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., van Es M.A., Hennekam E.A., Dooijes D., van Rheenen W., Medic J., Bourque P.R., Schelhaas H.J., van der Kooi A.J., de Visser M., et al. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012;21:3776&#x2013;3784. doi: 10.1093/hmg/dds199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds199</ArticleId><ArticleId IdType="pubmed">22645277</ArticleId></ArticleIdList></Reference><Reference><Citation>Chornenkyy Y., Fardo D.W., Nelson P.T. Tau and tdp-43 proteinopathies: Kindred pathologic cascades and genetic pleiotropy. Lab. Investig. 2019;99:993&#x2013;1007. doi: 10.1038/s41374-019-0196-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41374-019-0196-y</ArticleId><ArticleId IdType="pmc">PMC6609463</ArticleId><ArticleId IdType="pubmed">30742063</ArticleId></ArticleIdList></Reference><Reference><Citation>Weedon M.N., Hastings R., Caswell R., Xie W., Paszkiewicz K., Antoniadi T., Williams M., King C., Greenhalgh L., Newbury-Ecob R., et al. Exome sequencing identifies a dync1h1 mutation in a large pedigree with dominant axonal charcot-marie-tooth disease. Am. J. Hum. Genet. 2011;89:308&#x2013;312. doi: 10.1016/j.ajhg.2011.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2011.07.002</ArticleId><ArticleId IdType="pmc">PMC3155164</ArticleId><ArticleId IdType="pubmed">21820100</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms M.B., Allred P., Gardner R., Jr., Fernandes Filho J.A., Florence J., Pestronk A., Al-Lozi M., Baloh R.H. Dominant spinal muscular atrophy with lower extremity predominance: Linkage to 14q32. Neurology. 2010;75:539&#x2013;546. doi: 10.1212/WNL.0b013e3181ec800c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181ec800c</ArticleId><ArticleId IdType="pmc">PMC2918478</ArticleId><ArticleId IdType="pubmed">20697106</ArticleId></ArticleIdList></Reference><Reference><Citation>Beecroft S.J., McLean C.A., Delatycki M.B., Koshy K., Yiu E., Haliloglu G., Orhan D., Lamont P.J., Davis M.R., Laing N.G., et al. Expanding the phenotypic spectrum associated with mutations of dync1h1. Neuromuscul. Disord. 2017;27:607&#x2013;615. doi: 10.1016/j.nmd.2017.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2017.04.011</ArticleId><ArticleId IdType="pubmed">28554554</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito D., Suzuki N. Seipinopathy: A novel endoplasmic reticulum stress-associated disease. Brain. 2009;132:8&#x2013;15. doi: 10.1093/brain/awn216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn216</ArticleId><ArticleId IdType="pubmed">18790819</ArticleId></ArticleIdList></Reference><Reference><Citation>Craveiro Sarmento A.S., de Azevedo Medeiros L.B., Agnez-Lima L.F., Lima J.G., de Melo Campos J.T.A. Exploring seipin: From biochemistry to bioinformatics predictions. Int. J. Cell Biol. 2018;2018:5207608. doi: 10.1155/2018/5207608.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5207608</ArticleId><ArticleId IdType="pmc">PMC6192094</ArticleId><ArticleId IdType="pubmed">30402103</ArticleId></ArticleIdList></Reference><Reference><Citation>Datskevich P.N., Nefedova V.V., Sudnitsyna M.V., Gusev N.B. Mutations of small heat shock proteins and human congenital diseases. Biochem. Biokhimiia. 2012;77:1500&#x2013;1514. doi: 10.1134/S0006297912130081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297912130081</ArticleId><ArticleId IdType="pubmed">23379525</ArticleId></ArticleIdList></Reference><Reference><Citation>Asthana A., Raman B., Ramakrishna T., Rao Ch M. Structural aspects and chaperone activity of human hspb3: Role of the &#x201c;c-terminal extension&#x201d;. Cell Biochem. Biophys. 2012;64:61&#x2013;72. doi: 10.1007/s12013-012-9366-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12013-012-9366-x</ArticleId><ArticleId IdType="pubmed">22610661</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado L., Del Bo R., Castellotti B., Ratti A., Cereda C., Penco S., Soraru G., Carlomagno Y., Ghezzi S., Pensato V., et al. Mutations of fus gene in sporadic amyotrophic lateral sclerosis. J. Med. Genet. 2010;47:190&#x2013;194. doi: 10.1136/jmg.2009.071027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.2009.071027</ArticleId><ArticleId IdType="pubmed">19861302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon M.J., Baek W., Ki C.S., Kim H.Y., Koh S.H., Kim J.W., Kim S.H. Screening of the sod1, fus, tardbp, ang, and optn mutations in korean patients with familial and sporadic als. Neurobiol. Aging. 2012;33:1017.e17&#x2013;1017.e23. doi: 10.1016/j.neurobiolaging.2011.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.12.003</ArticleId><ArticleId IdType="pubmed">22244934</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Langenhove T., van der Zee J., Sleegers K., Engelborghs S., Vandenberghe R., Gijselinck I., Van den Broeck M., Mattheijssens M., Peeters K., De Deyn P.P., et al. Genetic contribution of fus to frontotemporal lobar degeneration. Neurology. 2010;74:366&#x2013;371. doi: 10.1212/WNL.0b013e3181ccc732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181ccc732</ArticleId><ArticleId IdType="pubmed">20124201</ArticleId></ArticleIdList></Reference><Reference><Citation>Paisan-Ruiz C., Dogu O., Yilmaz A., Houlden H., Singleton A. Spg11 mutations are common in familial cases of complicated hereditary spastic paraplegia. Neurology. 2008;70:1384&#x2013;1389. doi: 10.1212/01.wnl.0000294327.66106.3d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000294327.66106.3d</ArticleId><ArticleId IdType="pmc">PMC2730021</ArticleId><ArticleId IdType="pubmed">18337587</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlacchio A., Babalini C., Borreca A., Patrono C., Massa R., Basaran S., Munhoz R.P., Rogaeva E.A., St George-Hyslop P.H., Bernardi G., et al. Spatacsin mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010;133:591&#x2013;598. doi: 10.1093/brain/awp325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp325</ArticleId><ArticleId IdType="pmc">PMC2822627</ArticleId><ArticleId IdType="pubmed">20110243</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang S.Y., Hsu J.S., Teo K.C., Li Y., Kung M.H.W., Cheah K.S.E., Chan D., Cheung K.M.C., Li M., Sham P.C., et al. Burden of rare variants in als genes influences survival in familial and sporadic als. Neurobiol. Aging. 2017;58:238.e9&#x2013;238.e15. doi: 10.1016/j.neurobiolaging.2017.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.06.007</ArticleId><ArticleId IdType="pubmed">28709720</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura R., Sone J., Atsuta N., Tohnai G., Watanabe H., Yokoi D., Nakatochi M., Watanabe H., Ito M., Senda J., et al. Next-generation sequencing of 28 als-related genes in a japanese als cohort. Neurobiol. Aging. 2016;39:219.e1&#x2013;219.e8. doi: 10.1016/j.neurobiolaging.2015.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.11.030</ArticleId><ArticleId IdType="pubmed">26742954</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse H., Ishiura H., Mitsui J., Takahashi Y., Matsukawa T., Tanaka M., Doi K., Yoshimura J., Morishita S., Goto J., et al. Burden of rare variants in causative genes for amyotrophic lateral sclerosis (als) accelerates age at onset of als. J. Neurol. Neurosurg. Psychiatry. 2019;90:537&#x2013;542. doi: 10.1136/jnnp-2018-318568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318568</ArticleId><ArticleId IdType="pubmed">30355605</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Mazzini L., D&#x2019;Alfonso S., Corrado L., Canosa A., Moglia C., Manera U., Bersano E., Brunetti M., Barberis M., et al. The multistep hypothesis of als revisited: The role of genetic mutations. Neurology. 2018;91:e635&#x2013;e642. doi: 10.1212/WNL.0000000000005996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005996</ArticleId><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan S., Shatunov A., Sproviero W., Jones A.R., Shoai M., Hughes D., Al Khleifat A., Malaspina A., Morrison K.E., Shaw P.J., et al. A comprehensive analysis of rare genetic variation in amyotrophic lateral sclerosis in the uk. Brain. 2017;140:1611&#x2013;1618. doi: 10.1093/brain/awx082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx082</ArticleId><ArticleId IdType="pmc">PMC5445258</ArticleId><ArticleId IdType="pubmed">28430856</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Oh K.W., Kwon M.J., Oh S.I., Park J.S., Kim Y.E., Choi B.O., Lee S., Ki C.S., Kim S.H. Identification of mutations in korean patients with amyotrophic lateral sclerosis using multigene panel testing. Neurobiol. Aging. 2016;37:209.e9&#x2013;209.e16. doi: 10.1016/j.neurobiolaging.2015.09.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.09.012</ArticleId><ArticleId IdType="pubmed">26601740</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology. Genet. Med. 2015;17:405&#x2013;424. doi: 10.1038/gim.2015.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.30</ArticleId><ArticleId IdType="pmc">PMC4544753</ArticleId><ArticleId IdType="pubmed">25741868</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A., Moglia C., Lunetta C., Marinou K., Ticozzi N., Ferrante G.D., Scialo C., Soraru G., Trojsi F., Conte A., et al. Factors predicting survival in als: A multicenter italian study. J. Neurol. 2017;264:54&#x2013;63. doi: 10.1007/s00415-016-8313-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8313-y</ArticleId><ArticleId IdType="pubmed">27778156</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H.J., Debray T.P.A., Visser A.E., van Eijk R.P.A., Rooney J.P.K., Calvo A., Martin S., McDermott C.J., Thompson A.G., Pinto S., et al. Prognosis for patients with amyotrophic lateral sclerosis: Development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423&#x2013;433. doi: 10.1016/S1474-4422(18)30089-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J., Robins H., Niedermoser I., Wyles M., Heath P.R., Higginbottom A., Walsh T., Kazoka M., Project Min E.A.L.S.S.C., Ince P.G., et al. Targeted genetic screen in amyotrophic lateral sclerosis reveals novel genetic variants with synergistic effect on clinical phenotype. Front. Mol. Neurosci. 2017;10:370. doi: 10.3389/fnmol.2017.00370.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00370</ArticleId><ArticleId IdType="pmc">PMC5684183</ArticleId><ArticleId IdType="pubmed">29170628</ArticleId></ArticleIdList></Reference><Reference><Citation>Abecasis G.R., Auton A., Brooks L.D., DePristo M.A., Durbin R.M., Handsaker R.E., Kang H.M., Marth G.T., McVean G.A. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3498066</ArticleId><ArticleId IdType="pubmed">23128226</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L., World Federation of Neurology Research Group on Motor Neuron, D El escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Calvo A., Moglia C., Mazzini L., Mora G., PARALS study group Phenotypic heterogeneity of amyotrophic lateral sclerosis: A population based study. J. Neurol. Neurosurg. Psychiatry. 2011;82:740&#x2013;746. doi: 10.1136/jnnp.2010.235952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.235952</ArticleId><ArticleId IdType="pubmed">21402743</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson J.T., Thorvaldsdottir H., Winckler W., Guttman M., Lander E.S., Getz G., Mesirov J.P. Integrative genomics viewer. Nat. Biotechnol. 2011;29:24&#x2013;26. doi: 10.1038/nbt.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1754</ArticleId><ArticleId IdType="pmc">PMC3346182</ArticleId><ArticleId IdType="pubmed">21221095</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorvaldsdottir H., Robinson J.T., Mesirov J.P. Integrative genomics viewer (igv): High-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178&#x2013;192. doi: 10.1093/bib/bbs017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbs017</ArticleId><ArticleId IdType="pmc">PMC3603213</ArticleId><ArticleId IdType="pubmed">22517427</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Ferraro P.M., Riva N., Spinelli E.G., Domi T., Carrera P., Copetti M., Falzone Y., Ferrari M., Lunetta C., et al. Structural and functional brain signatures of c9orf72 in motor neuron disease. Neurobiol. Aging. 2017;57:206&#x2013;219. doi: 10.1016/j.neurobiolaging.2017.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.05.024</ArticleId><ArticleId IdType="pubmed">28666709</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiyama A., Niihori T., Warita H., Izumi R., Akiyama T., Kato M., Suzuki N., Aoki Y., Aoki M. Comprehensive targeted next-generation sequencing in japanese familial amyotrophic lateral sclerosis. Neurobiol. Aging. 2017;53:194.e1&#x2013;194.e8. doi: 10.1016/j.neurobiolaging.2017.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.01.004</ArticleId><ArticleId IdType="pubmed">28160950</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P., Henikoff S., Ng P.C. Predicting the effects of coding non-synonymous variants on protein function using the sift algorithm. Nat. Protoc. 2009;4:1073&#x2013;1081. doi: 10.1038/nprot.2009.86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2009.86</ArticleId><ArticleId IdType="pubmed">19561590</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunyaev S., Ramensky V., Koch I., Lathe W., 3rd, Kondrashov A.S., Bork P. Prediction of deleterious human alleles. Hum. Mol. Genet. 2001;10:591&#x2013;597. doi: 10.1093/hmg/10.6.591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/10.6.591</ArticleId><ArticleId IdType="pubmed">11230178</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>